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Ketamine, a non-competitive N -methyl-d-aspartate receptor antagonist, is rising in popu-
larity as a drug of abuse. Preliminary evidence suggests that chronic, heavy ketamine use
may have profound effects on spatial memory but the mechanism of these deficits is as
yet unclear. This study aimed to examine the neural mechanism by which heavy ketamine
use impairs spatial memory processing. In a sample of 11 frequent ketamine users and
15 poly-drug controls, matched for IQ, age, years in education. We used fMRI utilizing an
ROI approach to examine the neural activity of three regions known to support successful
navigation; the hippocampus, parahippocampal gyrus, and the caudate nucleus during a
virtual reality task of spatial memory. Frequent ketamine users displayed spatial memory
deficits, accompanied by and related to, reduced activation in both the right hippocampus
and left parahippocampal gyrus during navigation from memory, and in the left caudate dur-
ing memory updating, compared to controls. Ketamine users also exhibited schizotypal and
dissociative symptoms that were related to hippocampal activation. Impairments in spatial
memory observed in ketamine users are related to changes in medial temporal lobe activa-
tion. Disrupted medial temporal lobe function may be a consequence of chronic ketamine
abuse and may relate to schizophrenia-like symptomatology observed in ketamine users.
Keywords: ketamine, drug abuse, hippocampus, memory, spatial memory, NMDA receptor
INTRODUCTION
The N -methyl-d-aspartate-receptor (NMDA-R) antagonist keta-
mine when given acutely has profound effects on many aspects of
cognition and behavior. Subjective experiences of the drug include
reports of unusual bodily sensations, such as shrinking or growing
body parts, hallucinations, and “out-of-body” experiences. While
these side effects are considered problematic when ketamine is
employed as an anesthetic agent or, more recently, as a poten-
tial treatment for depression, the dissociative effects of ketamine
have driven its popularity as a recreational drug worldwide. Ket-
amine is now one of the UK’s leading club drugs after marijuana,
cocaine, and ecstasy (1) and is very popular in Hong Kong, where
87% of young drug users are estimated to be ketamine users (2).
With prevalence rising worldwide in recent years (3), there is an
urgent need to establish the consequences of long-term use of
the drug on psychological wellbeing and neurocognitive function.
Whilst an array of research has investigated the acute neurolog-
ical and psychological consequences of ketamine administration
[e.g., (4)], research addressing the long-term impact of the drug is
sparse.
In a recent, large scale longitudinal study, we assessed cognitive
function in a sample of frequent, infrequent, abstinent, and non-
ketamine users and again 12 months later (5). In keeping with
earlier reports (6), we found that ketamine-induced long-term
cognitive deficits were confined almost exclusively to frequent
users. Out of a wide battery of cognitive tests, heavy ketamine users
exhibited numerous cognitive impairments, but particularly a spe-
cific decline in spatial working memory, which was crucially linked
with increasing ketamine use over the year of testing. This suggests
that this effect was mediated by ketamine use and not a result of
pre-existing differences between ketamine users and controls. To
date, only this study has investigated spatial memory following
frequent ketamine use in humans, which is perhaps surprising
given the extensive preclinical evidence of impairment of spatial
memory with ketamine and other NMDA-antagonists [e.g., (7)]
where findings indicate that hippocampal NMDA-receptor activ-
ity and NMDA-receptor-dependent plasticity are fundamental for
spatial learning. In the only similar human study, Rowland et al. (8)
found that spatial memory performance was significantly poorer
than controls on a virtual MWM task following acute low-dose
ketamine, whereas no impairments were seen in other cognitive
tasks.
Spatial navigation to a hidden goal is thought to be sup-
ported by two different systems: a place or “allocentric” system
driven by hippocampal-dependent learning of environmental lay-
out which is viewpoint independent, and a taxon or “egocentric”
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system based on striatal-dependent learning of simple responses to
individual stimuli from a person centered perspective (9). Find-
ings from a variety of functional neuroimaging studies suggest
that the hippocampus underpins accurate navigation to a target
using “allocentric” memory whereas the dorsal striatum, in par-
ticular the caudate, is involved in action-based navigation from
a learned response (“egocentric” memory) [e.g., Ref. (10)]. Both
these systems are involved in successful navigation to a hidden
goal and some evidence suggests that when one system is impaired
the other may compensate. Evidence also suggests that the dorsal
striatum (caudate) is also involved in updating spatial memories
with new information (11).
Given the preliminary evidence of both acute and chronic
ketamine-induced spatial memory deficits in human beings, along
with the high density of NMDA receptors in the hippocampus and
the pivotal role of the NMDA-receptor in learning, the present
experiment aimed to explore spatial memory deficits observed
in people who take ketamine frequently by investigating whether
this impairment may be explained by differences in neural activ-
ity within the hippocampus. The task used in the current study
was designed to be similar to the Morris Water Maze paradigm
employed widely in rodent studies of hippocampal-dependent
spatial memory and navigation. It was derived from that used
in Ref. (11), involved the learning of several target locations in
a virtual field, using corrective feedback over multiple trials. We
hypothesized that chronic NMDA hypofunction in ketamine users
would disrupt the construction of a rich contextual representation
of the environment, thought to be necessary for the efficient nav-
igation toward a learned goal. Therefore, ketamine users would
be significantly poorer at navigating from memory compared to
poly-drug matched controls, while navigation to a visible tar-
get would be similar across groups. We focused our analysis on
three regions – the hippocampus, parahippocampal gyrus, and
the caudate-predicting that heavy ketamine use might affect the
recruitment of the hippocampus and parahippocampal gyrus to
a greater degree than the caudate, given previous preclinical evi-
dence of neurotoxicity in this region following chronic ketamine
administration (12).
METHODS AND MATERIALS
PARTICIPANTS
Eighteen ketamine users and 18 controls were recruited to the
study through the database of existing drug users at UCL’s clinical
psychopharmacology unit and via word of mouth. Ten subjects
were excluded from the study for a variety of reasons. Five due to
technical failure, three did not meet the ketamine usage criteria,
one due to shivering in the scanner, and one pressed the panic
button due to paranoia during scanning.
Complete data sets were collected for 11 ketamine users (8
male; 3 female) and 15 controls (10 male; 5 female) aged between
20 and 44 years old. Ketamine users were defined as those who
had self-administered ketamine at least three times per week for
the past year. Poly-drug using controls were broadly matched with
the ketamine group according to: their use of alcohol and tobacco;
age; gender; years in education; and premorbid IQ. Participants
were required to abstain from psychotropic drugs for at least 24 h
prior to testing, abstinence and recent drug use were verified with
urinalysis. Participants were also required to have no history of
head injury or psychiatric illness, to be right handed and fluent
in English. The study was approved by both the Imperial College
Research Ethics Committee and the UCL Graduate School ethics
committee. All participants were paid for their participation and
travel.
PROCEDURE
After giving informed consent, all participants were required to
provide a comprehensive self-report of their drug use history.
Urine samples were analyzed for verification of recent drug use.
A personal and family history of mental illness, alcohol, and drug
abuse was taken, and participants completed the Spot-the-Word
test (13) as an index of verbal IQ. Participants then completed a
training session in the virtual reality spatial memory task to be
used in the scanner. Total scan time was approximately 90 min.
Once the scans were finished, participants were guided to a quiet
room where they completed assessments of psychopathology and
neurocognitive function, detailed below.
SPATIAL NAVIGATION TASK
Virtual reality environment
The task was adapted from that created by Doeller et al. (11) using
UnrealEngine2 Runtime software (Epic Games). The virtual real-
ity environment consisted of a first person perspective view of
a grassy plain surrounded by distal mountains, clouds, and sun,
projected at infinity to provide orientation but not location infor-
mation. Surrounding the plain was a circular boundary, creating
an arena in which there was positioned a single intramaze land-
mark (a traffic cone). The viewpoint was approximately two virtual
meters above ground, with a field of view set at 90°. The arena was
180 virtual meters in diameter. The virtual heading and location
was recorded every 100 ms.
Training
Participants were familiarized with the experimental task during
training immediately prior to scanning. The training environment
differed from the experimental environment to prevent any unspe-
cific learning effects. These environments differed with respect to
the shape of the environment (square), the ground (desert), the
intramaze landmark (a tree and a bush), the global configuration
of background cues, and the objects used. Participants learned
the positions of four different objects and performed two trials
per object. The experiment proceeded when the experimenter was
satisfied that the task had been understood.
STIMULI, TASK AND TRIAL STRUCTURE
Once the task had begun, participants were required to complete
four initial learning trials to establish target locations for each
object (See Figure 1). At the beginning of each learning trial a sin-
gle cue (green man) appeared on the screen to signify for them to
get an object that was somewhere in the environment. Participants
looked for each of the four items individually, once only, on suc-
cessive trials. On finding the object, participants were instructed to
remember its location with reference to the position of the land-
mark, boundary and orientation cues. Walking over the object to
collect it constituted the end of each trial.
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FIGURE 1 | (A)Trial structure in experimental trials. Participants are
presented with an object cue and after a short delay must replace the
object in its remembered location. The object will appear in correct
location and participant must walk over it to collect it. (B) Virtual Arena
from a first person perspective. (i) In an experimental trial the object cue
will appear on screen, e.g., ball. (ii) Once the object has been located and
responded to, the object will appear in the correct location. On control
trials (iii) the same object will be cued (i.e., vase) and (iv) the participant is
required to walk directly to the visible location. Experimental trials contain
an intramaze landmark (traffic cone), the boundary (circular wall), and
orientation cues (mountains), control trials have no boundaries or landmark
and object remains visible throughout trial.
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During experimental trials (See Figure 1), participants were
presented with a cue (one of the four objects) presented on a blank
background for 2 s (cue phase). The cue signified participants to
move, as accurately as possible, to the location in which that object
was previously located, following a variable delay (fixation cross
2–6 s, mean 4 s). Using the right button keypad, participants nav-
igated from a randomly varied start position to the remembered
location and responded with the left index finger to indicate their
response location (replace phase). The object then reappeared in
it actual target location, the green man symbol appeared imme-
diately if the response had been registered and signified for the
participant to get the object. This allowed participants to re-encode
the correct location of the object and update, using available
cues before collecting it (feedback phase). Whereas the replace
phase aimed to tap into memory retrieval, the feedback phase was
thought to drive error-corrected learning by updating the spatial
representation including relationships between the object and the
boundary or landmark (See Figure 1A). In this sense, the par-
ticipant continued to learn the exact location throughout each
experimental block. A fixation cross was presented for a variable
inter-trial interval (ITI, mean 6 s, jittered to avoid fMRI acquisition
timing artifacts) before beginning the next trial.
Control trials were cued by a picture of an object, i.e., a vase
(Figure 1Aiii), which remained the same across every control trial.
After a short delay, the participant had to collect the visible object
from an infinite grassy plane with no boundary, intramaze land-
mark, or orientation cues (Figure 1Aiv). In this way, these trials
could be directly compared to the feedback phase of the experi-
mental cues which required a route-following navigation strategy
without requiring spatial memory or spatial processing of the envi-
ronmental location. Cue, delay, and ITI durations were the same
as the experimental trials.
Design
Overall there were four experimental trials per object, totaling
16 trials per block presented in pseudorandom order. There
were three experimental blocks and control trials were inter-
spersed throughout. The location of the landmark was moved
each block.
fMRI ACQUISITION
All imaging took place in a 3-T Phillips intera magnetic resonance
scanner (Medical Systems, Best, The Netherlands) equipped with
a SENSE head volume coil located at the Robert Steiner Mag-
netic Imaging Center at The Hammersmith Hospital. Functional
BOLD-sensitive T2* weighted functional images were acquired
using a single shot gradient-echo EPI pulse with the follow-
ing parameters: TR= 3000 ms, TE= 30 ms, flip angle 90°, slice
thickness= 3.25 mm, slices= 44, slice gap= 0 mm, in-plane reso-
lution= 2.19 mm× 2.19 mm, 32 slices per volume parallel to the
AC-PC line. The first five volumes were discarded as dummy scans
to allow for T1 equilibration. Participants were began by carrying
out a short 2 min resting state scan, followed by the virtual real-
ity spatial memory task during fMRI. The duration of the virtual
reality task was dependent on the speed of participant perfor-
mance. On completion, participants underwent a T1* structural
scan followed by a 1H-Magnetic Resonance Spectroscopy (MRS)
scan. Data from the resting state fMRI and MRS scan are reported
elsewhere (14).
fMRI ANALYSIS
Using SPM8 (Wellcome Department of Cognitive Neurology),
images were spatially realigned to the first image in the time series,
visually inspected for evidence of artifacts, and corrected for dis-
tortions according to the field map. Images were normalized to
the standard Montreal Neurological Institute reference brain and
spatially smoothed with an isotropic FWHM Gaussian kernel of
6 mm.
fMRI time series was modeled by a general linear model (GLM)
including regressors for cue, replace, and feedback phases for
each type of trial (memory or control). In the first level analy-
sis, all regressors were convolved with the SPM hemodynamic
response function. Data were high-pass filtered (cutoff period
1/120 HZ) and coefficients for each regressor were estimated using
a least-mean-squares fit of the model to the time series for each
participant.
The virtual reality task adopted by this study was chosen in
order to assess the neural correlates associated with spatial learning
and the different strategies used to navigate to a learned location.
A first level analysis computed linear contrasts of coefficients
for each participant specified as:
1. Navigation from cue offset to the point of dropping the object
compared to navigation to visible object in control trials. This
contrast revealed regions which are active when navigating
from memory.
2. Activation from when object was shown in correct location
and its subsequent collection (updating of spatial memory)
compared to walking to a visible object in control trials.
3. Walking toward a visible object compared to rest.
Contrast images from these first level contrasts were taken to
second level group analyses treating subject as a random effect.
Independent sample t -tests were used to test for effects at the
group level.
REGIONS OF INTEREST
We restricted our analyses to those brain regions found to play
key roles in navigation and spatial updating (See Figure 2): the
hippocampus, parahippocampal gyrus, and caudate nucleus (11).
Regions of interest were defined anatomically using the AAL atlas.
Left and right ROIs were analyzed separately. ROI analyses were
implemented using the Marsbar toolbox (15) and corrected for
multiple comparisons. All p-values reported are corrected.
NEUROCOGNITIVE ASSESSMENTS
Spot-the-Word (13) was used as an index of pre-morbid IQ.
Prose recall subtest of the Rivermead Behavioral Memory Test
(16) tapped episodic memory. Participants were required to recall
verbally as much as they could remember of a passage of prose
both immediately and after a delay.
Spatial N-back tapped spatial working memory. This is a com-
puter based task in which visual stimuli appeared sequentially
in one of six different locations around the center of the screen.
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FIGURE 2 | Regions of interest superimposed on MNI single subject template brain; pink= caudate, green=hippocampus, red=parahippocampal
gyrus.
Participants were required to give “Yes” or “No” button responses
according to whether the stimulus was presented in the same
position as the stimulus (1) one before (1-back), and subse-
quently, (2) two before (2-back). The N-back was analyzed using
the signal detection theory (17). D prime (d ′) scores were calcu-
lated as a sensitive measure of accuracy using the standardized
difference between the hit rate (signal) and false alarms rate (sig-
nal+ noise) using the equation: d ′= z(H)− z(F). C scores were
also calculated as an indicator of response bias, i.e., the inclination
to say no using the equation C = 0.5[z(H)+ z(F)].
Trailmaking Test (18) indexed psychomotor speed (part A) and
executive functioning (B–A).
Verbal and Semantic fluency tasks were used to tap into exec-
utive functioning and retrieval from semantic memory. Partici-
pants were provided with a single letter, e.g., “V” or a superordi-
nate category, e.g., four-footed animals, and asked to generate as
many exemplars as possible within 60 s.
PSYCHOLOGICAL WELL-BEING
Questionnaires used to tap psychological well-being were: Disso-
ciative Experiences Scale [DES (19)]; Beck Depression Inventory
[BDI; (20)], which assessed depressive symptoms over the previous
week; State-trait anxiety inventory [STAI; (21)]; Peter’s Delusion
Inventory [PDI; (22)] assessed delusional symptoms; Schizo-
typal Personality Questionnaire [SPQ; (23)] assessed schizo-
typal symptoms using DSM-III-R criteria for schizotypal per-
sonality disorder; Leeds Dependence Questionnaire [LDQ; (24)]
measured dependence upon ketamine.
ANALYSIS OF NEUROCOGNITIVE MEASURES AND CORRELATIONS
Data were analyzed using SPSS Statistics 19 (IBM). Data were
checked for assumptions of normality and heterogeneity of vari-
ance and then subjected to t -tests or repeated-measures ANOVAs
where appropriate. Correlations calculated Pearson’s correlation
coefficient where data were parametric, corrected for multiple
comparisons using the Bonferroni correction.
RESULTS
DEMOGRAPHICS
A total of 26 participants completed the study: 11 frequent ket-
amine users and 15 poly-drug-matched controls. Independent
sample t -tests revealed that the groups were demographically well-
matched, with no differences in age, number of years spent in
education or premorbid IQ as indexed by the “Spot-the-word” test
Table 1 | Demographic data (mean±SD) for ketamine users and
controls.
Ketamine users Poly-drug controls
No. of subjects 11 15
Age 28±4.03 26.13±5.25
Gender (male/female) 8/3 10/5
Years in education 13.80+ /3.29 16.47±3.96
Spot-the-word 47.4±7.09 46.93±5.85
Personal history of mental illness 1/11 1/15
Family history of drugs 2/11 1/15
Family history of mental illness 4/11 3/15
Family history of alcoholism 2/11 1/15
across the two groups (see Table 1). Although a higher proportion
of males than females were included in the study, there were no
differences in gender balance at the group level. There were also
no differences in the numbers of individuals with a personal men-
tal illness, family mental illness, family alcoholism, or family drug
abuse.
KETAMINE USE
All 11 participants in the ketamine group reported taking ketamine
at least three times per week for at least 1 year, with last use occur-
ring an average 1.6 (±0.70) days prior to testing (See Table 2).
Participants in the ketamine group reported taking ketamine for a
mean of 9.7± 3.62 years, a mean of 5.0± 1.15 days per week. Sub-
jects reported taking a mean of 3.9± 3.73 g per session and 10.2 g
(±7.42) per week. Ketamine users scored more highly than controls
on the Leeds Dependence Questionnaire [t (24) = 7.59, p< 0.001].
OTHER DRUG USE
Groups were matched for the number of regular tobacco and alco-
hol users, however, there were significantly more regular cannabis
and cocaine users in the ketamine group. Two out of the 11 ket-
amine users rated themselves as regular ecstasy users whilst none
of the control group met the criteria as regular users. Regular
users were defined as those who had used the drug once or more
within the preceding 30 days. The ketamine group reported smok-
ing both tobacco and cannabis more frequently and for more years
than the control group. While the ketamine group reported smok-
ing a larger quantity of cigarettes per day than controls, the days
taken to smoke“an eighth”(3.5 g) of cannabis (an index of amount
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Table 2 | Group means and SD for subjective report of drug use habits.
Ketamine
users
Poly-drug
controls
Cannabis No. of regular users 8/11* 4/15
Amount used (time to
smoke 1/8 oz)
2.56±2.19 15.00±12.66
Frequency (days/month) 21.00±12.25* 15.5±12.77
Last used (days) 3.00±4.87 4.50±6.35
Years of use 13.88±3.44* 8.00±2.45
Ecstasy No. of regular users 2/11 0/15
Amount used (mg/session) 277.78±253.86
Frequency (days/month) 1.18±1.49
Last used (days) 219.75±305.79
Years of use 10.22±6.28
Cocaine No. of regular users 4/11* 1/15
Amount used (g/session) 2.13±1.44 1.44
Frequency (days//month) 6.50±3.70 2.00
Last used (days) 6.75±9.54 3.00
Years of use 8.75±1.26 7.00
Alcohol No. of regular users 9/11 15/15
Amount used
(units/session)
6.89±5.56 5.00±3.38
Frequency (days//month) 15.33±9.95* 7.00±5.45
Last used (days) 2.22±2.99 3.60±3.64
Years of use 15.56±3.43 10.80±6.60
Tobacco No. of regular users 10/10 13/15
Amount used
(cigarettes/session)
10.30±5.90* 3.31±5.51
Frequency (days//month) 24.3±10.94* 11.31±14.06
Last used (days) 0.60±0.70 1.5±4.37
Years of use 12.90±6.24* 4.92±8.40
*p=0.05.
used) did not differ across groups. Groups were matched for the
duration, frequency, and amount of cocaine used. Groups were
also matched for the duration and quantity of alcohol consumed
per session, although the ketamine users reported drinking alcohol
more frequently (Table 2).
SPATIAL MEMORY TASK
Behavioral data (Figure 3)
Behavioral performance on the virtual reality task data was col-
lected in the form of “virtual units” of distance error between the
replaced object location and the correct object location. Data was
collected for every participant on each trial within the three blocks.
A large number of time-out trials meant that we were unable to
analyze performance on a trial-by-trial basis, instead we calculated
a mean score for each block. Control trials were not included in
the analysis as there was no behavioral measure on these trials.
Navigational performance was in a 2× 3 ANOVA (group×
block). There was a main effect of group F1,23= 4.42, p= 0.04,
attributable to greater error in the ketamine users across all
blocks, and a main effect of block (F2,56= 33.72, p< 0.001).
FIGURE 3 | Group performance on the ‘replace’ phase of the task over
the three blocks. Scores reflect the distance error between the location
the participant placed the object in and its correct location.
Pairwise comparisons revealed significant differences in perfor-
mance between block 1 and the subsequent blocks reflecting
poorer memory performance in the later blocks compared to
the first block. No significant difference was seen between mean
performances on the two later blocks.
fMRI DATA
Contrast 1: Navigation from memory
Analysis of the individual ROIs between groups revealed signifi-
cantly greater activation of the right hippocampus [t (24)= 2.77,
p= 0.03], as shown in Figure 4A, and the left parahippocam-
pal gyrus [t (24)= 2.81, p= 0.03], Figure 4B, in the control
group compared to the ketamine group for navigation from
memory compared to walking to a visible object, with similar
findings approaching significance in the right parahippocam-
pal gyrus [t (24)= 2.42, p= 0.07] and left caudate [t (24)= 2.35,
p= 0.08] (See Figure 4). Examination of the main effect of
task across both groups found no significant mean activation
across regions during navigation from memory relative to nav-
igation toward a visible cue. Analysis of individual within-group
activation revealed highly significant activation of the right hip-
pocampus [t (14)= 3.74, p= 0.003] and right parahippocampal
gyrus [t (14)= 3.51,p= 0.006] and significant activation of the left
hippocampus [t (14)= 3.21, p= 0.021]and left parahippocampal
gyrus [t (14)= 3.14, p= 0.014] in controls, again for the main
effect of task. None of these regions showed significant activation
in the ketamine group.
SPATIAL MEMORY UPDATING FROM FEEDBACK
ROI analysis revealed greater activation in controls compared to
ketamine users in the left caudate [t (24)= 2.6, p= 0.048] when
updating spatial memory with feedback compared to control
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FIGURE 4 | Parameter estimates across (A) the right hippocampus (B) left parahippocampal gyrus in ketamine users and controls for navigating from
memory compared to walking to a visible object.
FIGURE 5 | Parameter estimates of activations in the left caudate for ketamine users and controls between receiving feedback on the correct location
of object and collecting the object (memory updating) and walking to a visible object.
(walking to a visible object), see Figure 5. There were no significant
main effects of task.
NAVIGATING TO A VISIBLE OBJECT
Analysis showed no group differences or a main effect of task in
activation within our regions of interest during navigation to the
visible control object compared to simple cue processing.
COGNITIVE ASSESSMENTS
Trailmaking
Groups differed significantly on the Trailmaking A task of psy-
chomotor speed [t (24)= 2.79, p< 0.05], with slower response
in the ketamine group [t (24)= 2.79, p< 0.05], however, groups
did not differ on their raw scores on Trailmaking B task of
executive function [t (24)= 1.13, p= 0.27] (See Table 3). Group
scores of cognitive flexibility, a measure of executive function after
accounting for differences in psychomotor speed (Trailmaking B –
Trailmaking A), were not significantly different [t (13.48)=−0.48,
p= 0.64].
Fluency
The number of words generated did not differ significantly
between groups on verbal [t (24)=−0.87, p= 0.39] or category
fluency [t (24)= 0.24, p= 0.86].
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Table 3 | Group scores on neurocognitive assessments (Mean±SD).
Ketamine users Poly-drug controls
Trail making A 33.80±10.48* 24.33±6.59
Trail making B 46.20±14.53 40.07±12.41
Trail making total (B–A) 12.40±19.81 15.73±12.07
Verbal fluency 7.50±3.21 8.53±2.70
Category fluency 17.70±4.52 17.33±3.29
Prose recall immediate 6.45±2.42 7.87±3.43
Prose recall delayed 5.80±2.16 7.50±3.15
N-back (1-back)
No. correct responses 38.20±11.30 43.62±10.23
No. false alarms 7.50±6.24 3.15±3.96
d prime score 1.98±1.13* 3.05±1.19
C score 0.10±0.22 0.10±0.22
N-back (2-back)
No. correct responses 27.00±12.74 35.62±13.12
No. false alarms 12.60±6.50 7.77±6.26
d prime score 0.93±1.26* 1.85±1.28
C score 0.23±0.28 0.13±0.31
*p<0.05; **p<0.01.
Prose recall
A repeated-measures ANOVA showed a significant main effect of
delay (F1,23= 8.77, p< 0.007] in which delayed recall was signifi-
cantly poorer than immediate recall across both groups, the main
effect of group was not significant [F1,23= 1.72, p= 0.2].
Spatial N-back
Due to computer error, data for two participants in the con-
trol group could not be collected and is therefore not included
in the analysis. Using a repeated-measures ANOVA, a significant
main effect was found between the d ′ scores on the low and high
load tasks [F1,22= 19.06, p< 0.001] reflecting greater difficulty
in manipulating spatial information than maintaining it. There
was also a main effect of group (F1,22= 4.99, p< 0.05) whereby
accuracy was higher in the control than the ketamine group (see
Table 3.) The interaction between load and group was not signifi-
cant (F1,21= 0.08,p= 0.79). A further repeated-measures ANOVA
was carried out to assess for response bias between groups on the
low and high load tasks. C scores were not significantly differ-
ent between load (F1,21= 2.31, p= 0.14) or group (F1,21= 0.27,
p= 0.61).
PSYCHOLOGICAL WELLBEING
Significant group differences were found on all three fac-
tors underlying schizotypal traits (see Table 4). The ketamine
group scored higher on the Cognitive/Perceptual [t (22)= 2.70,
p< 0.05], Disorganization [t (24)= 3.55, p< 0.005] and Inter-
personal [t (22)= 2.17, p< 0.05] factors. There were significantly
greater depressive symptoms on the BDI [t (23)= 2.44, p< 0.05]
and anxiety on the STAI [t (24)= 3.82, p< 0.001] in the keta-
mine users compared to controls. The ketamine group scored more
highly on two scales of the Peters Delusion Inventory. The distress
[t (24)= 2.27, p< 0.05] and conviction [t (24)= 2.49, p< 0.05]
subscales reached significance, while Preoccupation scores did not
Table 4 | Group scores on assessments of psychological wellbeing
(Mean±SD).
Ketamine users Poly-drug controls
SPQ cognitive/perceptual 9.60±8.54* 3.00±2.88
SPQ interpersonal 9.56±8.16* 4.47±3.23
SPQ disorganization 9.20±3.91* 3.07±4.43
BDI 15.40±9.18* 6.27±9.16
STAI 44.60±8.92** 33.20±6.04
PDI distress 12.90±12.02* 3.67±5.52
PDI conviction 19.50±19.50* 5.40±8.46
PDI preoccupation 14.60±19.82 4.47±7.21
DES 27±21.67* 8.95±7.67
LDQ 15.25±5.65** 1.13±3.34
*p<0.05; **p= 0.01.
differ between groups [t (23)= 1.82, p= 0.08]. Significant dif-
ferences were seen between the two groups on the Dissociative
Experience Scale, in which the ketamine group scored more highly
than controls [t (24)= 2.54, p< 0.05].
Correlations
Parameter estimates were extracted from the first level analysis for
right hippocampal activation and were correlated with error in
spatial memory performance on the virtual reality task, schizo-
typal, and dissociative symptoms and amount of ketamine taken
per day in the ketamine group only to limit the chance of Type I
error. There was a negative correlation between mean error and
hippocampal activation for navigation trials in the ketamine group
(r =−0.78 p= 0.008). There were also highly significant nega-
tive correlations between total SPQ score (r =−0.816, p< 000.1)
and total DES score (r =−0.861, p< 0.001) and hippocampal
activation for navigation trials. A negative correlation between
amount of grams of ketamine taken per day and hippocampal acti-
vation approached significance following Bonferroni correction
(r =−0.696, p= 0.025).
DISCUSSION
The main findings of this study were that ketamine users showed
significantly less activation within the hippocampal complex
(including the right hippocampus and left parahippocampal
gyrus) than controls, when navigating to a learned object location
in a spatial memory task. Activation within the left caudate was also
significantly greater in the control group than the ketamine group
during memory updating. There were no group differences in acti-
vation when moving toward a visible object, tentatively suggesting
a specific effect of frequent ketamine use on spatial memory.
Given the pivotal role of the hippocampal complex in spatial
memory, it is compelling that we see such strong differences in
neural activity between ketamine users and controls in the right
hippocampus and parahippocampal gyrus during retrieval from
spatial memory. Our results provide the first human data to sug-
gest a long-term neural impact of frequent ketamine on spatial
memory processes. Both the hippocampus and the caudate have
been implicated in successful navigation to a target object, with
the former thought to be responsible for retrieval of a cognitive
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map and the latter thought to drive action-outcome learning that
enables successful navigation to a target over time (11). In light
of our present findings, we can conclude that the functional acti-
vation of these regions is disrupted in ketamine users. Behavioral
data also demonstrated spatial memory deficits in ketamine users,
as we hypothesized, and convincingly these deficits were negatively
correlated with hippocampal activation in ketamine users.
Given previous findings of the relationship between ketamine
use and spatial memory deficits (25), and a correlation between
degree of ketamine use and right hippocampal activation observed
in this study, the reduced activation observed in both the hip-
pocampal and caudal regions in our ketamine group are likely
due to repeated use of this drug. Whether the disruption in acti-
vation on a spatial memory task observed in this study is due to
structural damage in the hippocampus is unclear. The hippocam-
pus contains two major cell types, glutamatergic pyramidal cells
and GABAergic interneurons. GABA containing interneurons are
10 times more sensitive to NMDA-receptor antagonists than the
pyramidal neurons (26), of which parvalubumin (PV+) interneu-
rons are thought to be most affected by the drug. It is possible that
chronic ketamine inhibits PV+ interneurons thereby disinhibiting
excitatory pyramidal cells in the hippocampus, which in turn leads
to widespread glutamate-mediated excitotoxicity through AMPA
and kainite receptors (27). A significantly reduced density of PV+
interneurons has been found in the granule layer of the dentate
gyrus and the CA1-CA3 pyramidal cell layers following repeated
doses of ketamine in rats (28) and mice (29). “Place” cells are
hippocampal pyramidal cells and are thought to be responsible
for the encoding, construction and retrieval of a cognitive map of
the environment, necessary for efficient navigation (9). A reduc-
tion of PV+ cells within this region could give rise to the reduced
activation we see in our ketamine group during navigation from
memory and consequent spatial memory impairment.
Navigation from memory also produced greater activation in
the parahippocampal gyrus bilaterally in the control group but
not the ketamine group. The parahippocampal gyrus is thought
to encode the distance and allocentric direction of landmarks (e.g.,
large objects or barriers) in the environment, within which neu-
rons are thought to be broadly tuned to a those located at a specific
bearing from the navigator. Bidirectional associations between
the parahippocampal gyrus and perirhinal areas (thought to inte-
grate landmark locations with visual features), as well as between
the parahippocampal gyrus and hippocampus, place the parahip-
pocampal gyrus in an ideal position to drive the hippocampus (10)
in a way that pattern completion of the firing rates of place cells in
the dentate gyrus are always consistent with the navigator being in
a single location (30). Our results are in line with these previous
findings, which highlight the importance of the parahippocampal
gyrus in supporting a representation in spatial memory.
Differences between ketamine users and controls were observed
in the right, but not left hippocampus. The right hemisphere has
been well implicated in studies of spatial navigation, in which it is
thought to predict the use of an allocentric spatial representation
whereas the left hippocampus is involved in the sequential orga-
nization of successive choices within such an episode that may be
combined to support different aspects of navigation and episodic
memory (31). In our study activation in controls was observed in
both the left and right hippocampus but it may be that the weaker
task-related activation of the left is the reason for us only observing
differences on the right.
A reduction in the activation of the caudate nucleus during
memory updating was also observed in ketamine users com-
pared to controls. NMDA-receptor blockade is thought to disrupt
learning in the striatum and prevents instrumental control in the
form of learned action-outcome contingencies (A-O) or “goal-
directed” actions (32). The caudate has been found to express
long-term potentiation (LTP) that depends on the activation of
both dopamine receptors and NMDA glutamate receptors. In our
task, memory updating is assumed to occur in the time between
replacing the object from memory and collecting the object from
the correct location following feedback. This process of updat-
ing presumably invokes a prediction error signaling mechanism,
in which the navigator is required to learn from the error dis-
tance and adjust their spatial memory accordingly. Given studies
that have found glutamate-mediated dopamine depletion in the
brain following chronic ketamine use (33), disruptions in pre-
diction error signaling following acute ketamine (34) and given
the role of intact dopaminergic function in the coding of pre-
diction errors in the midbrain (35), it is possible that reduced
caudal activation in our ketamine sample is a result of NMDA
hypofunction, which impairs dopaminergic error signaling in the
associative cortico-basal ganglia system, including the caudate and
hippocampus. Glutamate modulates dopamine signaling at the
level of glutamatergic afferents to the PFC, which in turn mod-
ulate concentrations of dopamine in the striatum via excitatory
inputs to GABA neurons. We therefore speculate that the reduced
activation of the caudate observed in ketamine users during mem-
ory updating is a result of a series of downstream modification of
dopamine receptors related to NMDA hypofunction. Indeed, this
is supported by recent preclinical work that suggests that spa-
tial memory deficits in rats are driven by striatal dopaminergic
changes (36).
Spatial working memory deficits were observed behaviorally on
the N-back task, replicating previous findings (5) and we extended
these findings by demonstrating an impairment on a virtual reality
spatial memory task. In line with the findings from Doeller et al.
(11) performance on Block 1 was significantly better than Block 2
and 3. This was due to the landmark moving in each block, making
the task more difficult as previous locations interfere with memory.
Extraction of parameter estimates allowed us to compare behav-
ioral performance with neural activity at different stages within
the task. A negative correlation between hippocampal activity and
error in the ketamine group supports our hypothesis, in which
hippocampal activity is thought to underpin spatial memory per-
formance. Contrary to the findings of previous studies measuring
the impact of chronic ketamine administration (5, 37), the keta-
mine group performed as well as controls on all other cognitive
tasks, with exception of the spatial memory tasks in which ket-
amine users performed significantly worse than controls. This
may in part be due to better educational and IQ matching of
our sample with the control group than in previous studies. In
accordance with numerous previous studies into the psychiatric
consequences of ketamine use, subjects in this study scored greater
than controls on measures of depression, dissociative experiences,
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anxiety, schizotypy, dependency and delusional experiences [see
Morgan et al. (38) for a review]. This provides support for evidence
demonstrating the sustained dissociation and schizophrenic-like
symptoms in frequent ketamine users when drug free (39).
Intriguingly, schizotypal and dissociative symptoms were neg-
atively correlated with hippocampal activation in ketamine users.
This may be partly mediated by the negative correlation with
degree of ketamine use found in the ketamine users, i.e., that
heavier ketamine use results in both hippocampal dysfunction
and greater schizotypal and dissociative symptoms. However, the
correlations with symptoms were of a greater magnitude than
this correlation, so this may relate to the putative role of the hip-
pocampus in the genesis of schizophrenia. An inability to recruit
the hippocampus during memory tasks in patients with schiz-
ophrenia has been repeatedly observed [e.g., Ref. (40)] and has
been proposed to have a core etiological role in the disorder
(41). Increasing hippocampal dysfunction in humans has been
found to be associated with the transition from the prodromal
psychotic state to acute psychosis (29) and the latter study demon-
strated that a similar pattern of hippocampal dysfunction could be
invoked following repeated ketamine administration in a mouse
model. It has been demonstrated that a decrease in GABAergic
function within the hippocampus, of the kind that is posited to
happen following chronic ketamine administration, can also lead
to increases in dopaminergic activation in the ventral tegmental
area of rats (41). This may be one way in which the hippocam-
pal disruptions observed in ketamine users in this study produce
increases in schizophrenia-like symptoms, an explanation, which
also fits with theoretical accounts of the link between repeated
NDMA-antagonist use and schizophrenia (42, 43) that propose
dopaminergic sensitization following chronic ketamine use. A
recent theory has also suggested that glutamatergic disruptions in
hippocampal synaptic plasticity may directly impact on symptoms
by impairing the efficiency of hippocampal pattern separation,
resulting in spurious associations of the nature observed in delu-
sions (44). Future work with this population of users could aim to
address more directly the links between glutamatergically medi-
ated neurological changes and symptomatology in this group of
individuals.
Methodological considerations common to most recreational
drug research also apply to our study. All ketamine users were poly-
drug users and the nature of the group meant that matching them
with controls for other drug use was difficult, which limits how far
we can attribute the effects seen in the experimental group exclu-
sively to the effects of ketamine. There may also be pre-existing
differences between groups that draw users to take ketamine (45),
hence, it is hard to attribute the effects to chronic ketamine use
per se. In this study, we attempted to overcome some types of pre-
existing differences by matching groups for premorbid IQ, years
in education, personal mental illness, family history of mental ill-
ness. For a study of this kind, groups were relatively well-matched
for drug use with the exception of cocaine and MDMA cannabis,
where there were more regular users but for alcohol and tobacco
use the ketamine group also showed indications of higher use
on some self-reported metrics. It is also important to stress that
the recruitment criteria (absence of serious psychiatric comorbid-
ity and high literacy) used in this study, may have resulted in a
sample of highly functioning ketamine users, which might not be
representative of the majority. It is also important to stress that
the recruitment criteria (absence of serious psychiatric comorbid-
ity and high literacy) used in this study, may have resulted in a
sample of highly functioning ketamine users, which might not be
representative of the majority.
In summary, this study of a sample of chronic ketamine users
found impaired spatial memory and associated reduced activation
in three key regions of the brain known to be involved in successful
spatial navigation, the hippocampus, parahippocampal gyrus and
the caudate nucleus. Hippocampal changes were also related to
schizophrenia-like symptoms observed in ketamine users. Whilst
we do not yet know how long-lasting these neural changes are,
cautionary advice should be provided to the growing population
of recreational users of the damaging effects of ketamine on the
brain and aspects of cognitive function.
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